Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.Explore and learn more about Conference Series : World's leading Event Organizer
Natural Health News — A common vitamin may turn out to be a powerful weapon to fight certain antibiotic-resistant ‘superbugs’ that health experts see as a threat to public health.
In laboratory tests scientists found that a form of vitamin B3, nicotinamide, increased by up to 1,000 fold the ability of the immune system to kill Staph bacteria. The research, published in the Journal of Clinical Investigation, grew from the findings of a study into a rare genetic blood disorder called neutrophil-specific granule deficiency.
This disease is caused by a mutation in a specific gene, CEBPE, that regulates several antimicrobial factors in the body. Sufferers have significantly weakened immune systems, leaving them prone to severe, chronic and life-threatening infections, including Staph.
OMICS International through its 84 Open Access Initiative is committed to make genuine and reliable contributions to the scientific community. OMICS International hosted 84 open access articles Open Access articles, 560 Scientific conference Proceedings, 129 national symposiums and on Key word antibiotics in Global Events page. Global Events of Conference series make the perfect platform for global networking as it brings together renowned speakers and scientists across the globe to a most exciting and memorable scientific event filled with much enlightening interactive sessions, world class exhibitions of OMICS International Conferences.
Importance and scope:
In general, clinical studies are designed to add to medical knowledge related to the treatment, diagnosis, and prevention of diseases or conditions. Some common reasons for conducting clinical studies include: Evaluating one or more interventions (for example, drugs, medical devices, approaches to surgery or radiation therapy) for treating a disease, syndrome, or condition Finding ways to prevent the initial development or recurrence of a disease or condition. These can include medicines, vaccines, or lifestyle changes, among other approaches.Evaluating one or more interventions aimed at identifying or diagnosing a particular disease or condition,Examining methods for identifying a condition or the risk factors for that condition.
Market Analysis:
New technologies and the outsourcing of antibiotics to lower-cost countries will slow the recent annual increases in expenditures in the U.S. to a 3.3% compound annual growth rate (CAGR) over the forecast period. Clinical trial spending in 2010 is an estimated $25 billion and is expected to reach $28.5 billion by 2014. The report provides an overview of clinical development phases, the regulatory issues involved, and the factors influencing clinical trial costs. An overview is provided of new technologies that will be affecting the clinical trial process in the near future.
Associations
Companies:
Best Confrences:
This page will be updated regularly.
This page was last updated on April 20, 2024